Alyeska Investment Group’s Nautilus Biotechnolgy NAUT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $184K | Hold |
253,468
| – | – | ﹤0.01% | 536 |
|
|
2025
Q1 | $218K | Hold |
253,468
| – | – | ﹤0.01% | 482 |
|
|
2024
Q4 | $426K | Sell |
253,468
-187,550
| -43% | -$315K | ﹤0.01% | 520 |
|
|
2024
Q3 | $1.26M | Hold |
441,018
| – | – | 0.01% | 448 |
|
|
2024
Q2 | $1.03M | Hold |
441,018
| – | – | 0.01% | 436 |
|
|
2024
Q1 | $1.3M | Hold |
441,018
| – | – | 0.01% | 386 |
|
|
2023
Q4 | $1.32M | Sell |
441,018
-4,968
| -1% | -$14.9K | 0.01% | 366 |
|
|
2023
Q3 | $1.41M | Hold |
445,986
| – | – | 0.01% | 391 |
|
|
2023
Q2 | $1.73M | Sell |
445,986
-30,443
| -6% | -$118K | 0.01% | 393 |
|
|
2023
Q1 | $1.32M | Hold |
476,429
| – | – | 0.01% | 360 |
|
|
2022
Q4 | $858K | Hold |
476,429
| – | – | 0.01% | 356 |
|
|
2022
Q3 | $1.01M | Sell |
476,429
-19,557
| -4% | -$41.5K | 0.01% | 336 |
|
|
2022
Q2 | $1.33M | Hold |
495,986
| – | – | 0.02% | 444 |
|
|
2022
Q1 | $2.15M | Hold |
495,986
| – | – | 0.02% | 409 |
|
|
2021
Q4 | $2.57M | Hold |
495,986
| – | – | 0.03% | 399 |
|
|
2021
Q3 | $3.05M | Sell |
495,986
-919,653
| -65% | -$5.65M | 0.04% | 417 |
|
|
2021
Q2 | $13.5M | Buy |
1,415,639
+668,648
| +90% | +$6.39M | 0.16% | 177 |
|
|
2021
Q1 | $10.3M | Sell |
746,991
-53,009
| -7% | -$730K | 0.13% | 189 |
|
|
2020
Q4 | $8.68M | Sell |
800,000
-6,400
| -0.8% | -$69.4K | 0.12% | 206 |
|
|
2020
Q3 | $8.72M | Buy |
+806,400
| New | +$8.72M | 0.13% | 192 |
|